It's the end of 2012, and that means it's time to take a look back at the year in retrospect. We'll be reading through the naughty and nice lists (we've already checked them twice), counting down the 25 best-performing stocks and the 25 worst-performing stocks in the health care sector this year.
In this segment, Motley Fool health care analyst Brenton Flynn takes a look at #5 on the nice list, Galena BioPharma (NASDAQ: GALE ) , and how this company left investors with more than a little something extra in their stockings this year.
While looking at 2012 performance is useful, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.
Your 98.79% Chance at Beating the Market
If you're interested in the best odds in the universe ? including a 70.84% chance at DOUBLING the market's return over the long haul ? here's some very good news for you... Motley Fool Supernova is re-opening to new members for the first time ever on January 15!
Get this: We arrived at these odds from 10,000 random back-tested portfolios made up of Co-founder David Gardner's personal stock picks between December 2002 and December 2011...
So, what's INSIDE Motley Fool Supernova?!? Simply enter your email address. And David Gardner will take you on a personal tour. And reveal his up-to-the-minute top picks for 3-D Printing, Entertainment, Social Networking, Personal Wellness, Next-Gen Education, and more!



